Hikma bolsters injectables franchise with $425M deal for Custopharm, but FTC review loomsnews2021-09-27T15:11:53+00:00September 27th, 2021|Fierce Pharma|
Amgen’s Repatha gains an edge on rival Praluent with FDA approval to treat children with rare cholesterol conditionnews2021-09-27T14:01:58+00:00September 27th, 2021|Fierce Pharma|
Eli Lilly recalls single lot of glucagon emergency kits on concern of potency lossnews2021-09-27T13:50:13+00:00September 27th, 2021|Fierce Pharma|
Eli Lilly recalls single lot of glucagon emergency kits on potency concernsnews2021-09-27T13:50:13+00:00September 27th, 2021|Fierce Pharma|
Biogen used charity giving to illegally boost multiple sclerosis drug sales, Humana lawsuit saysnews2021-09-27T13:36:39+00:00September 27th, 2021|Fierce Pharma|
Merck grabs lifeline for problematic Keytruda liver cancer approval thanks to Asian trial winnews2021-09-27T13:03:10+00:00September 27th, 2021|Fierce Pharma|
Genentech study reveals health equity perception gap between patients and doctorsnews2021-09-24T21:43:49+00:00September 24th, 2021|Fierce Pharma|
Facing class action lawsuit over insulin pricing, Novo Nordisk inks $100M settlement with disgruntled investorsnews2021-09-24T19:32:49+00:00September 24th, 2021|Fierce Pharma|
Facing lawsuit over insulin pricing disclosures, Novo Nordisk inks $100M settlement with disgruntled investorsnews2021-09-24T19:32:49+00:00September 24th, 2021|Fierce Pharma|
Gilead, Merck and others slapped with ‘pay-for-delay’ lawsuits over lucrative HIV and cholesterol medsnews2021-09-24T15:39:15+00:00September 24th, 2021|Fierce Pharma|
